Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death

Abstract

Introduction:The present study evaluated the application of incorporating non-linear J/U-shaped relationships between mean HbA1c and cholesterol levels into risk scores for predicting acute myocardial infarction (AMI) and non-AMI-related sudden cardiac death (SCD) respectively, amongst patients with type 2 diabetes mellitus.Methods: This was a territory-wide cohort study of patients with type 2 diabetes mellitus above the age 40 and free from prior AMI and SCD, with or without prescriptions of anti-diabetic agents between January 1st, 2009 to December 31st, 2009 at government-funded hospitals and clinics in Hong Kong. Patients recruited were followed up until 31 December 2019 or their date of death. Risk scores were developed for predicting incident AMI and non-AMI-related SCD. The performance of conditional inference survival forest (CISF) model compared to that of random survival forests (RSF) model and multivariate Cox model. Results:This study included 261 308 patients (age = 66.0 ± 11.8 years old, male = 47.6%, follow-up duration = 3552 ± 1201 days, diabetes duration = 4.77 ± 2.29 years). Mean HbA1c and low high-density lipoprotein-cholesterol (HDL-C) were significant predictors of AMI on multivariate Cox regression. Mean HbA1c was linearly associated with AMI, whilst HDL-C was inversely associated with AMI. Mean HbA1c and total cholesterol were significant multivariate predictors with a J-shaped relationship with non-AMI-related SCD. The AMI and SCD risk scores had an area under the curve (AUC) of 0.666 (95% confidence interval (CI) = [0.662, 0.669]) and 0.677 (95% CI = [0.673, 0.682]), respectively. CISF significantly improves prediction performance of both outcomes compared to RSF and multivariate Cox models. Conclusion:A holistic combination of demographic, clinical and laboratory indices can be used for the risk stratification of patients with type 2 diabetes mellitus for AMI and SCD.This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway

“…Diabetes is a well-recognized risk factor for the development of AF ( Xiong et al, 2018 ), adverse cardiovascular events ( Lee et al, 2021a ; Lee et al, 2021b ), complications involving different organs ( Lee et al, 2020 ), and mortality. Of the different classes of antidiabetic drugs, thiazolidinediones act by activating PPAR-γ ( Lebovitz, 2019 ; Veettil et al, 2020 ).…”

Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population‐based cohort study

“…The prognostic values of HbA1c and lipid variability have been increasingly explored over the past decades. However, prior studies have mostly focused on the prediction of all‐cause mortality or cardiovascular events 12,22 with only a limited number of studies focusing on arrhythmic or SCD outcomes 23 . Although the underlying pathophysiology remains incompletely elucidated, there are several possible contributing factors towards the increased arrhythmic risk amongst patients with high glycemic and lipid variability.…”

Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis

“…Patients or the public were not involved in any aspect of this study. The system has been previously used by both our team and other teams in Hong Kong [ 11 – 13 ].…”